StonvexLoading…
StonvexStonvexStonvexCore line items from INLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.58M | $18.02M | $16.89M | $14.02M |
Operating Income | $-1.79M | $-173.50K | $1.11M | $827.32K |
Net Income | $-1.87M | $-546.22K | $519.27K | $24.03K |
EPS (Diluted) | $-0.44 | $-0.13 | $0.11 | $0.01 |
Total Assets | $17.31M | $18.57M | $19.03M | $19.94M |
Total Liabilities | $5.92M | $7.94M | $9.28M | $11.37M |
Cash & Equivalents | $2.53M | $2.49M | $1.22M | $2.70M |
Free Cash Flow OCF − CapEx | $579.49K | $3.42M | $673.42K | $1.79M |
Shares Outstanding | 4.48M | 4.25M | 4.11M | 4.07M |